Attorneys Investigating Lawsuits Over Xarelto Bleeding Problems

Xarelto Lawsuit

The attorneys at Morgan & Morgan have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered serious bleeding events. Pharmaceutical companies, including the makers of Xarelto, have a duty to ensure that their drugs are reasonably safe for use – and failure to do so may be grounds for compensation. Our lawyers are working hard to get those hurt by the drug the compensation they are entitled to.

While bleeding is a common complication associated with anticoagulants, it has been alleged that Xarelto is more dangerous than traditional blood thinners because no antidote exists to reverse its blood-thinning effects. This means that, in the event of an emergency, patients may be at risk for irreversible bleeding problems, including life-threatening internal and gastrointestinal hemorrhaging.

If you or a loved one suffered a serious bleeding event after taking Xarelto, you may have legal recourse. For more information, contact us today to have your case reviewed, free of charge.

Compensation Possibilities

The plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for past and future medical bills, lost wages, pain and suffering and, in cases of death, funeral expenses. Additionally, they are seeking punitive damages, which are typically awarded to punish the defendant and deter other companies from acting similarly.

Why Are Lawsuits Being Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is dangerous and defective. The plaintiffs claim that, unlike traditional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding in the event of an emergency. Plaintiffs in the lawsuits allege serious and fatal injuries, including cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

  • The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
  • The makers of the drug continue to market Xarelto as a safe anticoagulant option.
  • Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user in the event of a bleeding complication.
  • Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.
  • Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.

Visit this page for more information on the alleged health risks of Xarelto.

Multidistrict Litigation Trial Dates Set

The attorneys in the Complex Litigation Group at Morgan and Morgan have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.

The benefits of MDL suits compared to class action lawsuits is that MDL suits tend to be a more efficient process and addresses client’s individual needs rather than grouping them all together in the same class. More information on information on the Morgan and Morgan’s MDL can be found here.

Morgan and Morgan attorney Michael Goetz has been appointed to the lawsuit’s Plaintiff’s Steering Committee. Goetz describes the committee’s tireless work, “The Plaintiff’s Steering Committee is currently reviewing millions of pages of documents produced by the defendants.” Goetz adds “[w]e believe these documents will support our contention that the risk of suffering a major bleeding event while on Xarelto is much greater than warned about by the manufacturer.”

The class of those eligible to receive compensation is still open, but time to join is limited.

Statute of Limitations Running Out

If you or a loved one suffered serious bleeding problems while taking Xarelto, the attorneys at Morgan & Morgan would like to hear from you. The statute of limitations bars claims not brought within the short time period of the injury, contact us today for a free consultation on your possible legal options. We will review your experience and tell you whether you qualify for compensation.

How Much Does an Attorney Cost?

At Morgan & Morgan, our lawyers work on a contingency fee basis. This means you only pay us if we are able to provide a favorable outcome in your case, such as a settlement or verdict in your favor. We have previously handled lawsuits on behalf of patients who allegedly experience similar bleeding problems from the use of the blood thinner Pradaxa. While that litigation has settled for $650 million, we believe that patients who suffered serious bleeding injuries from Xarelto may have similar legal recourse.

If you or a loved one suffered serious bleeding problems while taking Xarelto, the attorneys at Morgan & Morgan would like to hear from you. For more information on filing a lawsuit, contact us today for a free case review.